688238 和元生物
已收盘 11-20 15:00:00
资讯
新帖
简况
和元生物(688238)披露以集中竞价交易方式首次回购公司股份的公告,11月19日股价下跌1.5%
证券之星 · 11-19 22:34
和元生物(688238)披露以集中竞价交易方式首次回购公司股份的公告,11月19日股价下跌1.5%
和元生物(688238)11月18日主力资金净卖出1528.83万元
证券之星 · 11-19 08:28
和元生物(688238)11月18日主力资金净卖出1528.83万元
CG0070三期临床取得积极结果,和元生物溶瘤病毒CDMO能力受关注
同花顺 · 11-18 17:21
CG0070三期临床取得积极结果,和元生物溶瘤病毒CDMO能力受关注
股市必读:和元生物(688238)11月16日收盘跌10.88%,主力净流入391.26万元
证券之星 · 11-17
股市必读:和元生物(688238)11月16日收盘跌10.88%,主力净流入391.26万元
和元生物(688238)披露以集中竞价交易方式回购股份的回购报告书,11月13日股价上涨5.68%
证券之星 · 11-13
和元生物(688238)披露以集中竞价交易方式回购股份的回购报告书,11月13日股价上涨5.68%
和元生物举办投资者开放日:解码诺奖转化与mRNA产业化新机遇
证券之星 · 11-13
和元生物举办投资者开放日:解码诺奖转化与mRNA产业化新机遇
和元生物(688238)11月12日主力资金净卖出883.48万元
证券之星 · 11-13
和元生物(688238)11月12日主力资金净卖出883.48万元
股市必读:和元生物新发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》
证券之星 · 11-13
股市必读:和元生物新发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》
和元生物(688238)披露回购股份事项前十名股东持股情况,11月11日股价下跌0.15%
证券之星 · 11-11
和元生物(688238)披露回购股份事项前十名股东持股情况,11月11日股价下跌0.15%
和元生物(688238)披露以集中竞价交易方式回购股份的方案,11月09日股价上涨1.08%
证券之星 · 11-09
和元生物(688238)披露以集中竞价交易方式回购股份的方案,11月09日股价上涨1.08%
股市必读:和元生物新发布《第四届董事会第十四次会议决议公告》
证券之星 · 11-09
股市必读:和元生物新发布《第四届董事会第十四次会议决议公告》
和元生物(688238.SH)拟2500万元至5000万元回购公司股份
智通财经 · 11-08
和元生物(688238.SH)拟2500万元至5000万元回购公司股份
和元生物新提交“和元和初”等2件商标注册申请
证券之星 · 11-07
和元生物新提交“和元和初”等2件商标注册申请
和元生物(688238)11月5日主力资金净卖出2163.96万元
证券之星 · 11-06
和元生物(688238)11月5日主力资金净卖出2163.96万元
股市必读:和元生物新发布《关于公司控股股东、实际控制人、董事长提议回购公司股份的提示性公告》
证券之星 · 11-02
股市必读:和元生物新发布《关于公司控股股东、实际控制人、董事长提议回购公司股份的提示性公告》
股市必读:和元生物三季报 - 第三季度单季净利润同比增长22.33%
证券之星 · 10-30
股市必读:和元生物三季报 - 第三季度单季净利润同比增长22.33%
和元生物(688238)9月30日股东户数1.95万户,较上期增加33.98%
证券之星 · 10-29
和元生物(688238)9月30日股东户数1.95万户,较上期增加33.98%
和元生物(688238)10月27日主力资金净卖出388.37万元
证券之星 · 10-28
和元生物(688238)10月27日主力资金净卖出388.37万元
和元生物(688238)10月21日主力资金净买入504.04万元
证券之星 · 10-22
和元生物(688238)10月21日主力资金净买入504.04万元
和元生物(688238)10月19日主力资金净卖出1333.01万元
证券之星 · 10-20
和元生物(688238)10月19日主力资金净卖出1333.01万元
加载更多
公司概况
公司名称:
上海和元生物技术(集团)股份有限公司
所属行业:
研究和试验发展
上市日期:
2022-03-22
主营业务:
上海和元生物技术(集团)股份有限公司的主营业务是细胞和基因治疗CRO/CDMO业务。公司的主要产品是基因治疗载体研制服务、基因功能研究服务、基因检测服务、Non-IND服务、IND-CMC服务、Pre-IND配套服务、临床I&II期生产服务、临床III期生产服务、商业化生产服务、Post-IND配套服务、细胞制备服务、细胞衍生物制备服务、细胞存储及配套服务、生物原料、生物制剂产品、试剂、试剂盒及其他产品。
发行价格:
13.23
{"stockData":{"symbol":"688238","market":"SH","secType":"STK","nameCN":"和元生物","latestPrice":5.57,"timestamp":1795158000000,"preClose":5.91,"halted":0,"volume":19224670,"delay":0,"changeRate":-0.0575,"floatShares":647000000,"shares":649000000,"eps":-0.3376,"marketStatus":"已收盘","change":-0.34,"latestTime":"11-20 15:00:00","open":5.78,"high":5.84,"low":5.54,"amount":109000000,"amplitude":0.0508,"askPrice":5.57,"askSize":60,"bidPrice":5.56,"bidSize":284,"shortable":0,"etf":0,"ttmEps":-0.3376,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":5,"adr":0,"adjPreClose":5.91,"symbolType":"stock_kcb","openAndCloseTimeList":[[1795138200000,1795145400000],[1795150800000,1795158000000]],"highLimit":6.5,"lowLimit":5.32,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":649036700,"isCdr":false,"pbRate":2.86,"roa":"--","roe":"--","epsLYR":-0.37,"committee":-0.211945,"marketValue":3615000000,"turnoverRate":0.0297,"status":1,"afterMarket":{"amount":10583,"volume":1900,"close":5.57,"buyVolume":0,"sellVolume":1100,"time":1795160037746,"indexStatus":"已收盘 11-20 15:30:00","preClose":5.91},"floatMarketCap":3606000000},"requestUrl":"/m/hq/s/688238","defaultTab":"news","newsList":[{"id":"2684497700","title":"和元生物(688238)披露以集中竞价交易方式首次回购公司股份的公告,11月19日股价下跌1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2684497700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684497700?lang=zh_cn&edition=full","pubTime":"2026-11-19 22:34","pubTimestamp":1795098856,"startTime":"0","endTime":"0","summary":"截至2026年11月19日收盘,和元生物报收于5.91元,较前一交易日下跌1.5%,最新总市值为38.36亿元。该股当日开盘6.0元,最高6.02元,最低5.7元,成交额达1.25亿元,换手率为3.3%。近日,和元生物披露《关于以集中竞价交易方式首次回购公司股份的公告》。回购实施期限为2026年11月6日至2027年2月5日,预计回购金额为2,500万元至5,000万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111900041555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684910785","title":"和元生物(688238)11月18日主力资金净卖出1528.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684910785","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684910785?lang=zh_cn&edition=full","pubTime":"2026-11-19 08:28","pubTimestamp":1795048138,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月18日收盘,和元生物报收于6.0元,下跌4.0%,换手率4.03%,成交量26.1万手,成交额1.58亿元。11月18日的资金流向数据方面,主力资金净流出1528.83万元,占总成交额9.69%,游资资金净流入1683.71万元,占总成交额10.67%,散户资金净流出154.88万元,占总成交额0.98%。近5日资金流向一览见下表:和元生物融资融券信息显示,融资方面,当日融资买入1341.9万元,融资偿还1816.1万元,融资净偿还474.2万元。融资融券余额1.7亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111900007104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684996111","title":"CG0070三期临床取得积极结果,和元生物溶瘤病毒CDMO能力受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2684996111","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684996111?lang=zh_cn&edition=full","pubTime":"2026-11-18 17:21","pubTimestamp":1794993660,"startTime":"0","endTime":"0","summary":" CG Oncology近日公布CG0070(cretostimogene)PIVOT-006III期临床顶线结果,研究达到主要终点,患者复发风险降低68%(HR=0.32,P<0.0001),为溶瘤病毒在非肌层浸润性膀胱癌(NM ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261118/c681962041.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261118/c681962041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688238","CDMO","BK4139","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684564437","title":"股市必读:和元生物(688238)11月16日收盘跌10.88%,主力净流入391.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684564437","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684564437?lang=zh_cn&edition=full","pubTime":"2026-11-17 02:20","pubTimestamp":1794853225,"startTime":"0","endTime":"0","summary":"截至2026年11月16日收盘,和元生物报收于6.47元,下跌10.88%,换手率8.67%,成交量56.11万手,成交额3.79亿元。交易信息汇总股价提醒11月16日和元生物收盘报6.47元,跌10.88%,当日成交3.79亿元。前10个交易日资金流向情况:主力资金累计净流入1469.96万元,股价累计下跌10.88%;融资余额累计增加2075.26万元,融券余量累计增加0股。资金流向11月16日主力资金净流入391.26万元,占总成交额1.03%;游资资金净流入3147.9万元,占总成交额8.3%;散户资金净流出3539.16万元,占总成交额9.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700001374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683506498","title":"和元生物(688238)披露以集中竞价交易方式回购股份的回购报告书,11月13日股价上涨5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2683506498","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683506498?lang=zh_cn&edition=full","pubTime":"2026-11-13 22:04","pubTimestamp":1794578660,"startTime":"0","endTime":"0","summary":"截至2026年11月13日收盘,和元生物报收于7.26元,较前一交易日上涨5.68%,最新总市值为47.12亿元。该股当日开盘7.1元,最高7.65元,最低7.1元,成交额达4.77亿元,换手率为10.03%。近日,和元生物披露《关于以集中竞价交易方式回购股份的回购报告书》。回购价格不高于9.00元/股,回购股份用于维护公司价值及股东权益,并在披露回购结果公告12个月后通过集中竞价方式出售,3年内完成出售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300042918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683847572","title":"和元生物举办投资者开放日:解码诺奖转化与mRNA产业化新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2683847572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683847572?lang=zh_cn&edition=full","pubTime":"2026-11-13 19:07","pubTimestamp":1794568023,"startTime":"0","endTime":"0","summary":"2026年11月13日, 和元生物于上海临港和元智造精准医疗产业基地成功举办“聚光成势,元创未来”——2026年投资者开放日活动。潘珺屹强调,和元生物作为底层技术的“践行者”,已依托临港基地前瞻性布局,致力于将前沿科技的突破转化为产业链中确定的商业机遇,全面赋能创新疗法的商业化落地。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026111300036196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238","162414"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683497355","title":"和元生物(688238)11月12日主力资金净卖出883.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2683497355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683497355?lang=zh_cn&edition=full","pubTime":"2026-11-13 08:16","pubTimestamp":1794528981,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月12日收盘,和元生物报收于6.87元,上涨1.78%,换手率4.94%,成交量31.96万手,成交额2.21亿元。11月12日的资金流向数据方面,主力资金净流出883.48万元,占总成交额4.0%,游资资金净流入460.36万元,占总成交额2.09%,散户资金净流入423.12万元,占总成交额1.92%。近5日资金流向一览见下表:和元生物融资融券信息显示,融资方面,当日融资买入2139.98万元,融资偿还2215.79万元,融资净偿还75.81万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300009001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683519876","title":"股市必读:和元生物新发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2683519876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683519876?lang=zh_cn&edition=full","pubTime":"2026-11-13 01:49","pubTimestamp":1794505751,"startTime":"0","endTime":"0","summary":"截至2026年11月12日收盘,和元生物报收于6.87元,上涨1.78%,换手率4.94%,成交量31.96万手,成交额2.21亿元。公司公告汇总:公司于2026年11月6日董事会审议通过以集中竞价方式回购股份议案,并披露当日登记在册的前十名股东持股情况,潘讴东持股122,928,436股,占总股本18.94%。前十名股东合计持股占比35.51%,其中潘讴东持股122,928,436股,占总股本18.94%。前十名无限售条件股东持股比例与前十名股东一致,持股数量相同。所有数据已合并普通账户与融资融券信用账户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300002100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682300404","title":"和元生物(688238)披露回购股份事项前十名股东持股情况,11月11日股价下跌0.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682300404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682300404?lang=zh_cn&edition=full","pubTime":"2026-11-11 22:16","pubTimestamp":1794406581,"startTime":"0","endTime":"0","summary":"截至2026年11月11日收盘,和元生物报收于6.75元,较前一交易日下跌0.15%,最新总市值为43.81亿元。近日,上海和元生物技术(集团)股份有限公司发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》。公告显示,公司于2026年11月6日召开第四届董事会第十四次会议,审议通过以集中竞价方式回购公司股份的议案。前十名股东合计持股占比35.51%,其中潘讴东持股122,928,436股,占总股本18.94%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100046146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682800237","title":"和元生物(688238)披露以集中竞价交易方式回购股份的方案,11月09日股价上涨1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682800237","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682800237?lang=zh_cn&edition=full","pubTime":"2026-11-09 20:18","pubTimestamp":1794226732,"startTime":"0","endTime":"0","summary":"截至2026年11月9日收盘,和元生物报收于6.56元,较前一交易日上涨1.08%,最新总市值为42.58亿元。该股当日开盘6.54元,最高6.8元,最低6.54元,成交额达1.64亿元,换手率为3.78%。近日,和元生物披露《关于以集中竞价交易方式回购股份的方案》公告。回购价格不高于9.00元/股,回购股份用于维护公司价值及股东权益,并在披露回购结果公告12个月后通过集中竞价方式出售,3年内完成出售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900019698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682825266","title":"股市必读:和元生物新发布《第四届董事会第十四次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682825266","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682825266?lang=zh_cn&edition=full","pubTime":"2026-11-09 02:23","pubTimestamp":1794162189,"startTime":"0","endTime":"0","summary":"公司公告汇总第四届董事会第十四次会议决议公告上海和元生物技术(集团)股份有限公司于2026年11月6日召开第四届董事会第十四次会议,审议通过《关于以集中竞价方式回购公司股份方案的议案》。董事会授权公司管理层全权办理本次回购股份相关事宜,授权有效期自董事会审议通过之日起至回购事项办理完毕之日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900000677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681842629","title":"和元生物(688238.SH)拟2500万元至5000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2681842629","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681842629?lang=zh_cn&edition=full","pubTime":"2026-11-08 15:57","pubTimestamp":1794124635,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和元生物(688238.SH)发布公告,公司拟2500万元至5000万元回购公司股份,回购股份价格不高于9元/股,回购股份用于维护公司价值及股东权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681481088","title":"和元生物新提交“和元和初”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2681481088","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681481088?lang=zh_cn&edition=full","pubTime":"2026-11-07 21:56","pubTimestamp":1794059776,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日上海和元生物技术(集团)股份有限公司新提交“和元和初”等2件商标注册申请。商标申请详情如下:今年以来上海和元生物技术(集团)股份有限公司新申请注册商标38件,截止目前公司共持有注册商标235件,另有126件商标尚在注册申请中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110700018883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681797881","title":"和元生物(688238)11月5日主力资金净卖出2163.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681797881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681797881?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:19","pubTimestamp":1793924379,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月5日收盘,和元生物报收于6.72元,上涨5.49%,换手率6.17%,成交量39.97万手,成交额2.67亿元。11月5日的资金流向数据方面,主力资金净流出2163.96万元,占总成交额8.11%,游资资金净流入109.02万元,占总成交额0.41%,散户资金净流入2054.94万元,占总成交额7.7%。近5日资金流向一览见下表:和元生物融资融券信息显示,融资方面,当日融资买入2939.42万元,融资偿还2372.15万元,融资净买入567.27万元,连续3日净买入累计1096.96万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600008367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680788076","title":"股市必读:和元生物新发布《关于公司控股股东、实际控制人、董事长提议回购公司股份的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680788076","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680788076?lang=zh_cn&edition=full","pubTime":"2026-11-02 07:13","pubTimestamp":1793574795,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘,和元生物报收于6.25元,下跌1.42%,换手率7.84%,成交量50.76万手,成交额3.24亿元。公司公告汇总:控股股东、实际控制人、董事长潘讴东提议以自有及自筹资金回购股份,金额2500–5000万元,回购股份拟于披露实施结果后12个月起集中竞价出售,并须在3年内完成处置。交易信息汇总资金流向10月30日主力资金净流入629.14万元,占总成交额1.94%;游资资金净流入1301.53万元,占总成交额4.02%;散户资金净流出1930.67万元,占总成交额5.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200001915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679323226","title":"股市必读:和元生物三季报 - 第三季度单季净利润同比增长22.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679323226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679323226?lang=zh_cn&edition=full","pubTime":"2026-10-30 05:32","pubTimestamp":1793309563,"startTime":"0","endTime":"0","summary":"当日关注点交易信息汇总:10月29日主力资金净流入869.76万元,游资资金净流入1892.31万元,散户资金净流出2762.08万元。股本股东变化:截至2026年9月30日股东户数达1.95万户,较6月30日增长33.98%,户均持股由4.46万股降至3.33万股。业绩披露要点:2026年第三季度主营收入同比上升40.04%至8472.51万元,归母净利润同比上升22.33%至-4469.26万元。公司公告汇总:公司将于2026年11月23日召开第三季度业绩说明会,董事长、董事总经理、财务负责人、董秘及独立董事将出席。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000007430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679740819","title":"和元生物(688238)9月30日股东户数1.95万户,较上期增加33.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679740819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679740819?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:56","pubTimestamp":1793271419,"startTime":"0","endTime":"0","summary":"证券之星消息,近日和元生物披露,截至2026年9月30日公司股东户数为1.95万户,较6月30日增加4950.0户,增幅为33.98%。户均持股数量由上期的4.46万股减少至3.33万股,户均持股市值为29.43万元。在医疗服务行业个股中,和元生物股东户数低于行业平均水平,截至9月30日,医疗服务行业平均股东户数为4.99万户。从股价来看,2026年6月30日至2026年9月30日,和元生物区间涨幅为63.28%,在此期间股东户数增加4950.0户,增幅为33.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900045084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678480292","title":"和元生物(688238)10月27日主力资金净卖出388.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678480292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678480292?lang=zh_cn&edition=full","pubTime":"2026-10-28 08:47","pubTimestamp":1793148423,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月27日收盘,和元生物报收于6.07元,下跌5.89%,换手率3.19%,成交量20.67万手,成交额1.3亿元。10月27日的资金流向数据方面,主力资金净流出388.37万元,占总成交额3.0%,游资资金净流入222.8万元,占总成交额1.72%,散户资金净流入165.57万元,占总成交额1.28%。近5日资金流向一览见下表:和元生物融资融券信息显示,融资方面,当日融资买入1238.57万元,融资偿还1209.12万元,融资净买入29.45万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800014264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677276986","title":"和元生物(688238)10月21日主力资金净买入504.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677276986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677276986?lang=zh_cn&edition=full","pubTime":"2026-10-22 08:33","pubTimestamp":1792629208,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月21日收盘,和元生物报收于6.75元,下跌2.17%,换手率3.81%,成交量24.64万手,成交额1.68亿元。10月21日的资金流向数据方面,主力资金净流入504.04万元,占总成交额3.01%,游资资金净流入1165.0万元,占总成交额6.95%,散户资金净流出1669.04万元,占总成交额9.96%。近5日资金流向一览见下表:和元生物融资融券信息显示,融资方面,当日融资买入2167.55万元,融资偿还1960.55万元,融资净买入207.0万元,连续3日净买入累计490.84万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200007066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676373626","title":"和元生物(688238)10月19日主力资金净卖出1333.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676373626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676373626?lang=zh_cn&edition=full","pubTime":"2026-10-20 08:26","pubTimestamp":1792455985,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月19日收盘,和元生物报收于6.51元,下跌5.52%,换手率6.68%,成交量43.24万手,成交额2.83亿元。10月19日的资金流向数据方面,主力资金净流出1333.01万元,占总成交额4.72%,游资资金净流入1287.35万元,占总成交额4.55%,散户资金净流入45.65万元,占总成交额0.16%。近5日资金流向一览见下表:和元生物融资融券信息显示,融资方面,当日融资买入2642.51万元,融资偿还2450.42万元,融资净买入192.09万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000005230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795174230466,"stockEarnings":[{"period":"1week","weight":-0.1397},{"period":"1month","weight":-0.1435},{"period":"3month","weight":-0.1882},{"period":"6month","weight":-0.0619},{"period":"1year","weight":-0.2014},{"period":"ytd","weight":-0.1126}],"compareEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.0422},{"period":"3month","weight":-0.0839},{"period":"6month","weight":-0.1301},{"period":"1year","weight":-0.0935},{"period":"ytd","weight":-0.0986}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海和元生物技术(集团)股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"19517人(较上一季度增加33.98%)","perCapita":"33172股","listingDate":"2022-03-22","address":"上海市浦东新区国际医学园区紫萍路908弄19号楼","registeredCapital":"64903万元","survey":" 上海和元生物技术(集团)股份有限公司的主营业务是细胞和基因治疗CRO/CDMO业务。公司的主要产品是基因治疗载体研制服务、基因功能研究服务、基因检测服务、Non-IND服务、IND-CMC服务、Pre-IND配套服务、临床I&II期生产服务、临床III期生产服务、商业化生产服务、Post-IND配套服务、细胞制备服务、细胞衍生物制备服务、细胞存储及配套服务、生物原料、生物制剂产品、试剂、试剂盒及其他产品。","listedPrice":13.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和元生物,688238,和元生物股票,和元生物股票老虎,和元生物股票老虎国际,和元生物行情,和元生物股票行情,和元生物股价,和元生物股市,和元生物股票价格,和元生物股票交易,和元生物股票购买,和元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}